Replies to post #3135 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

...the baseline expectation of [sBLA] acceptance might make such disclosure not particularly material and they can sit on an acceptance longer before issuing a PR about it...

That's my contention exactly. For instance, RVNC may be planning a "2023 goals" PR on Monday to coincide with the opening of the JPM conference.